LABCORP HOLDINGS INC.

Insider Sentiment (TTM):

Last Purchase:-Last Sale:2026-06-08Shares Purchased (TTM):0Shares Sold (TTM):50,596.54

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:72,681,123Shares Outstanding:82,300,000Institutional Ownership Pct.:88.31%

Earnings Market Reaction:

Filing Date:2026-05-04Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in Services-Medical Laboratories

NTRA DGX GH CELC CAI RDNT

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Deferred Revenue Revenue Recognized1	-	-	-	-	-	-	-	-	-	79	-	-
Cash And Cash Equivalents At Carrying Value	981	532	598	647	369	1,519	1,517	265	99	537	728	1,931
Allowance For Doubtful Accounts Receivable	-	-	-	-	-	-	39	34	34	-	33	31
Accounts Receivable Net Current	2,289	2,104	2,109	2,121	2,123	1,944	2,059	2,089	2,084	1,913	1,957	1,905
Unbilled Contracts Receivable	162	157	156	156	151	153	166	158	120	185	108	138
Inventory Net	498	535	522	508	488	493	483	442	475	475	461	488
Prepaid Expense And Other Assets Current	630	693	694	655	658	698	685	618	678	655	700	660
Assets Current	4,559	4,021	4,079	4,087	3,790	4,807	4,910	3,571	3,457	3,765	3,954	5,121
Assets Of Disposal Group Including Discontinued Op…	-	-	-	-	-	-	-	-	-	0	0	0
Property Plant And Equipment Net	3,066	3,082	3,113	3,134	3,091	3,045	3,050	2,933	2,898	2,912	2,821	2,762
Goodwill	6,955	6,790	6,682	6,551	6,421	6,370	6,482	6,220	6,219	6,143	6,332	6,182
Intangible Assets Net Excluding Goodwill	3,636	3,596	3,571	3,494	3,487	3,489	3,541	3,332	3,394	3,342	3,276	3,154
Investments In Affiliates Subsidiaries Associates …	147	154	168	160	168	16	17	18	18	27	40	67
Deferred Income Taxes And Other Assets Current	-	-	-	-	-	-	-	-	-	-	8	6
Other Assets Noncurrent	725	751	648	633	647	652	613	639	546	537	457	426
Assets	19,087	18,393	18,262	18,060	17,604	18,379	18,613	16,712	16,531	16,725	16,886	17,719
Deferred Income Tax Assets Net	-	-	-	-	-	-	-	-	-	0	-	-
Accounts Payable Current	696	841	669	793	718	876	661	761	696	828	691	713
Disposal Group Including Discontinued Operation As…	-	-	-	-	-	-	-	-	-	0	0	0
Accrued Liabilities Current	852	848	878	836	770	871	758	708	649	804	690	658
Deferred Revenue Current	405	439	392	398	388	392	403	388	378	422	361	350
Liabilities Current
Liabilities Current	2,641	2,824	2,629	2,717	2,065	3,330	3,412	4,065	3,942	3,225	2,901	2,183
Operating Lease Liability Current	183	191	187	186	183	185	184	182	171	166	162	155
Finance Lease Liability Current	5	5	5	4	5	6	6	7	6	6	6	7
Long Term Debt Current	500	500	-	-	-	1,000	-	-	-	-	-	-
Long Term Debt Noncurrent	5,834	5,085	5,083	5,077	5,569	5,331	5,352	3,047	3,048	4,055	4,428	5,042
Operating Lease Liability Noncurrent	657	683	692	713	696	676	701	643	625	649	662	624
Finance Lease Liability Noncurrent	62	63	64	66	67	74	75	77	77	79	80	82
Liabilities Of Disposal Group Including Discontinu…	-	-	-	-	-	-	-	-	-	0	0	0
Deferred Income Taxes And Other Tax Liabilities No…	456	455	-	-	-	383	-	-	-	-	-	-
Other Liabilities Noncurrent	692	648	639	643	498	517	528	484	468	409	423	419
Liabilities	10,342	9,756	9,549	9,571	9,282	10,313	10,427	8,692	8,556	8,835	8,994	8,914
Common Stock Value	7	8	8	8	8	8	8	8	8	8	8	8
Additional Paid In Capital Common Stock	0	0	33	2	36	3	0	13	82	38	5	94
Liabilities Of Disposal Group Including Discontinu…	-	-	-	-	-	-	-	-	-	0	0	0
Retained Earnings Accumulated Deficit	-8,784	8,640	-8,698	-8,498	-8,456	8,303	-8,276	-8,178	-8,055	7,888	-8,070	-8,836
Accumulated Other Comprehensive Income Loss Net Of…	-63	-28	-42	-35	-192	-262	-113	-192	-185	-59	-209	-154
Liabilities And Stockholders Equity	19,087	18,393	18,262	18,060	17,604	18,379	18,613	16,712	16,531	16,725	16,886	17,719
Stockholders Equity
Stockholders Equity	8,729	8,620	8,697	8,473	8,307	8,052	8,170	8,006	7,960	7,875	7,873	10,342
Net Income Loss	-	-	-	-	-	-	170	206	228	-	184	189
Assets
Assets Current
Liabilities And Stockhold…
Shares Outstanding	82	82	83	83	84	83	84	84	84	84	85	89

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	3.07%	7.59%	17.62%	-	-	-	-	-	-	-	-	-
2025	0.88%	9.24%	1.67%	6.38%	6.30%	9.63%	4.60%	-0.49%	6.94%	-8.17%	-5.49%	-12.57%
2024	-0.49%	2.30%	5.35%	-2.17%	-5.54%	-8.29%	5.08%	0.53%	4.90%	-7.11%	-13.89%	-1.04%
2023	-	-	-	-1.08%	-4.36%	-6.83%	7.72%	13.44%	14.52%	-1.03%	-6.49%	-2.26%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 50+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Liquidity Ratios
Current Ratio	1.73	1.42	1.55	1.50	1.84	1.44	1.44	0.88	0.88	1.17	1.36	2.35
Quick Ratio	1.30	0.99	1.09	1.08	1.28	1.09	1.10	0.62	0.58	0.82	0.96	1.82
Working Capital	1.92B	1.20B	1.45B	1.37B	1.73B	1.48B	1.50B	-493.40M	-485.00M	540.20M	1.05B	2.94B
Leverage & Debt
Debt to Equity	1.18	1.13	1.10	1.13	1.12	1.28	1.28	1.09	1.07	1.12	1.14	0.86
Interest Coverage TTM	6.45	6.18	5.74	5.25	5.02	5.22	1.51	1.51	1.44	1.45	2.11	2.46
Debt Ratio	0.54	0.53	0.52	0.53	0.53	0.56	0.56	0.52	0.52	0.53	0.53	0.50
Efficiency & Turnover
Asset Turnover TTM	0.77	0.76	0.75	0.78	0.77	0.74	0.72	0.73	0.67	0.66	0.62	0.58
Days Sales Outstanding TTM	56.92	52.95	55.25	56.97	58.26	54.11	57.64	58.37	65.71	55.51	66.54	67.68
Receivables Turnover TTM	6.41	6.89	6.61	6.41	6.26	6.74	6.33	6.25	5.56	6.58	5.49	5.39
Per Share Metrics
Diluted EPS TTM	11.35	10.46	10.22	9.10	8.67	8.84	5.17	5.34	5.12	4.77	7.60	9.33
Free Cash Flow Per Share TTM	16.82	14.50	16.62	15.13	13.78	13.06	10.04	10.13	7.94	10.04	11.73	12.81
Dividend Per Share TTM	7.37	7.29	7.31	7.32	5.83	5.82	10.42	7.53	7.58	7.35	2.23	3.69
Margin Metrics
Gross Profit Margin TTM	28.83%	28.76%	28.45%	28.14%	27.89%	27.86%	27.92%	28.00%	27.74%	27.67%	28.23%	29.03%
Operating Profit Margin TTM	10.18%	9.92%	9.69%	8.83%	8.28%	8.35%	5.88%	5.97%	5.83%	5.97%	7.03%	8.24%
Net Profit Margin TTM	6.66%	6.28%	6.21%	5.66%	5.55%	5.73%	3.43%	3.60%	3.52%	3.44%	5.85%	7.48%
Growth Metrics
Net Revenue Growth (1Y)	7.34%	7.25%	8.28%	7.98%	7.13%	6.97%	12.47%	12.37%	11.80%	2.51%	-17.77%	-25.62%
Net Income Growth (1Y)	28.82%	17.49%	96.12%	69.61%	68.60%	78.47%	-34.07%	-45.82%	-56.68%	-67.32%	-62.37%	-58.31%
EPS Growth (1Y)	30.86%	18.48%	98.25%	71.03%	69.61%	85.28%	-32.03%	-42.85%	-54.46%	-65.82%	-60.80%	-56.62%
Valuation Metrics
P/E TTM	23.26	23.69	27.67	28.38	26.27	25.37	42.22	37.18	41.30	45.99	25.47	21.35
P/B TTM	2.51	2.41	2.72	2.56	2.31	2.35	2.25	2.09	2.25	2.44	2.14	1.72
P/S TTM	1.55	1.49	1.72	1.61	1.46	1.46	1.45	1.34	1.46	1.58	1.49	1.60
Market Cap	21.90B	20.76B	23.67B	21.66B	19.20B	18.93B	18.41B	16.74B	17.90B	19.22B	16.85B	17.74B
Enterprise Value	27.26B	25.82B	28.16B	26.10B	24.40B	23.75B	22.26B	19.53B	20.85B	22.75B	20.56B	20.86B
Calculated Values
Free Cash Flow TTM	1.38B	1.21B	1.38B	1.26B	1.15B	1.10B	843.20M	852.30M	667.50M	874.10M	1.02B	1.14B
Net Debt	5.36B	5.06B	4.49B	4.43B	5.20B	4.82B	3.84B	2.79B	2.95B	3.52B	3.71B	3.12B
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-08Sale

Owner: Kyle, Kathryn W

Title: EVP, Chief Legal Officer

Shares: 762

Price/Share: $263.89

Value: $201,084.18

Shares Owned: 3,813

Relationship: Officer

Ownership: Direct

2026-05-11Sale

Owner: Schechter, Adam H

Title: President & CEO

Shares: 5,903

Price/Share: $254.50

Value: $1,502,313.50

Shares Owned: 107,234

Relationship: Director,Officer

Ownership: Direct

2026-03-27Sale

Owner: Meltzer, Jonathan C

Title: EVP, Operations

Shares: 839

Price/Share: $267.05

Value: $224,054.95

Shares Owned: 3,620

Relationship: Officer

Ownership: Direct

2026-03-27Sale

Owner: Wilkinson, Peter J

Title: SVP, Chief Accounting Officer

Shares: 1,633

Price/Share: $267.05

Value: $436,092.65

Shares Owned: 1,852

Relationship: Officer

Ownership: Direct

2026-03-03Sale

Owner: Schechter, Adam H

Title: President & CEO

Shares: 8,705

Price/Share: $279.96

Value: $2,437,051.80

Shares Owned: 80,773

Relationship: Director,Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-08	Kyle, Kathryn W	Officer	EVP, Chief Legal Officer	Direct	Sale	762	263.89	$201,084.18	3,813	4
2026-05-11	Schechter, Adam H	Director,Officer	President & CEO	Direct	Sale	5,903	254.50	$1,502,313.50	107,234	4
2026-03-27	Meltzer, Jonathan C	Officer	EVP, Operations	Direct	Sale	839	267.05	$224,054.95	3,620	4
2026-03-27	Wilkinson, Peter J	Officer	SVP, Chief Accounting Officer	Direct	Sale	1,633	267.05	$436,092.65	1,852	4
2026-03-03	Schechter, Adam H	Director,Officer	President & CEO	Direct	Sale	8,705	279.96	$2,437,051.80	80,773	4
2026-02-27	Van, Der Vaart Sandra D	Officer	EVP, Corporate Affairs	Direct	Sale	548	284.91	$155,999.62	2,579	4
2026-02-24	Caveney, Brian J	Officer	EVP, Pres of ED, CMO & CSO	Direct	Sale	1,500	286.31	$429,465.00	30,107	4
2026-02-19	Wilkinson, Peter J	Officer	SVP, Chief Accounting Officer	Direct	Sale	666	277.94	$185,108.04	1,852	4
2026-02-12	Meltzer, Jonathan C	Officer	EVP, Operations	Direct	Sale	87	290.42	$25,266.54	2,782	4
2026-02-11	Schechter, Adam H	Director,Officer	President & CEO	Direct	Sale	5,273	284.38	$1,499,535.74	87,343	4
2026-02-10	Meltzer, Jonathan C	Officer	EVP, Operations	Direct	Sale	91	276.79	$25,187.89	2,696	4
2026-02-09	Meltzer, Jonathan C	Officer	EVP, Operations	Direct	Sale	88	275.53	$24,246.64	2,869	4
2025-11-11	Schechter, Adam H	Director,Officer	President & CEO	Direct	Sale	5,745	262.75	$1,509,498.75	87,574	4
2025-10-31	Parham, Richelle P	Director	-	Direct	Sale	7,009	254.28	$1,782,248.52	2,469	4
2025-08-13	Van, Der Vaart Sandra D	Officer	EVP, Chief Legal Officer	Direct	Sale	3,903	271.42	$1,059,352.26	2,274	4
2025-08-11	Schechter, Adam H	Director,Officer	President & CEO	Direct	Sale	5,643	266.78	$1,505,439.54	93,319	4
2025-07-30	Gilliland, Dwight Gary	Director	-	Direct	Sale	2,000	264.95	$529,900.00	6,656	4
2025-07-29	Wilkinson, Peter J	Officer	SVP, Chief Accounting Officer	Direct	Sale	202	261.02	$52,726.04	1,852	4
2025-07-24	Anderson, Kerrii B	Director	-	Direct	Sale	3,500	280.00	$980,000.00	8,666	4
2025-07-01	Anderson, Kerrii B	Director	-	Direct	Sale	500	265.00	$132,500.00	12,166	4
2025-06-11	Anderson, Kerrii B	Director	-	Direct	Sale	500	260.00	$130,000.00	12,666	4
2025-06-03	Caveney, Brian J	Officer	EVP, Pres of ED, CMO & CSO	Direct	Sale	2,000	247.00	$494,000.00	30,067	4
2025-05-12	Schechter, Adam H	Director,Officer	President & CEO	Direct	Sale	6,105	248.73	$1,518,496.65	98,962	4
2025-05-01	Wilkinson, Peter J	Officer	SVP, Chief Accounting Officer	Direct	Sale	829	242.27	$200,841.83	2,054	4
2025-05-01	Van, Der Vaart Sandra D	Officer	EVP, Chief Legal Officer	Direct	Sale	1,900	238.36	$452,884.00	2,244	4
2025-03-28	Summy, Amy B.	Officer	EVP, Chief Marketing Officer	Direct	Sale	758	231.67	$175,605.86	5,302	4
2025-03-28	Schroeder, Mark S	Officer	EVP, Pres Diagnostics & COO	Direct	Sale	2,635	231.67	$610,450.45	4,960	4
2025-03-05	Anderson, Kerrii B	Director	-	Direct	Sale	500	255.63	$127,815.00	13,166	4
2025-02-28	Schroeder, Mark S	Officer	EVP, Pres Diagnostics & COO	Direct	Sale	5,339	249.23	$1,330,638.97	4,960	4
2025-02-25	Van, Der Vaart Sandra D	Officer	EVP, Chief Legal Officer	Direct	Sale	1,314	251.30	$330,208.20	2,171	4
2025-02-24	Summy, Amy B.	Officer	EVP, Chief Marketing Officer	Direct	Sale	226	250.40	$56,590.40	4,545	4
2025-02-18	Wilkinson, Peter J	Officer	SVP, Chief Accounting Officer	Direct	Sale	1,413	246.10	$347,739.30	1,993	4
2025-02-11	Schechter, Adam H	Director,Officer	President & CEO	Direct	Sale	6,121	244.62	$1,497,319.02	86,445	4
2025-01-07	Anderson, Kerrii B	Director	-	Direct	Sale	1,000	235.00	$235,000.00	12,722	4
2024-12-02	Eisenberg, Glenn A	Officer	Executive Vice President	Direct	Sale	11,711	240.43	$2,815,675.73	31,289	4
2024-12-02	Gilliland, Dwight Gary	Director	-	Direct	Sale	1,000	241.00	$241,000.00	7,712	4
2024-11-22	Summy, Amy B.	Officer	EVP, Chief Marketing Officer	Direct	Sale	3,672	238.91	$877,158.06	4,319	4
2024-11-21	Van, Der Vaart Sandra D	Officer	EVP, Chief Legal Officer	Direct	Sale	1,000	239.42	$239,420.00	2,670	4
2024-11-11	Schechter, Adam H	Director,Officer	President & CEO	Direct	Sale	6,189	243.47	$1,506,835.83	87,441	4
2024-10-24	Anderson, Kerrii B	Director	-	Direct	Sale	1,000	230.00	$230,000.00	13,722	4
2024-08-19	Van, Der Vaart Sandra D	Officer	EVP, Chief Legal Officer	Direct	Sale	2,000	227.05	$454,100.00	3,670	4
2024-08-15	Eisenberg, Glenn A	Officer	Chief Financial Officer, EVP	Direct	Sale	15,000	223.61	$3,354,150.00	31,289	4
2024-08-08	Anderson, Kerrii B	Director	-	Direct	Sale	586	225.00	$131,850.00	14,722	4
2024-08-05	Berberian, Lance	Officer	EVP, CIO & CTO	Direct	Sale	12,093	229.37	$2,773,771.41	15,921	4
2024-05-14	Van, Der Vaart Sandra D	Officer	EVP, Chief Legal Officer	Direct	Sale	2,000	210.84	$421,680.00	5,637	4
2024-05-02	Anderson, Kerrii B	Director	-	Direct	Sale	250	200.10	$50,025.00	15,722	4
2024-04-29	Wilkinson, Peter J	Officer	SVP, Chief Accounting Officer	Direct	Sale	2,439	204.33	$498,360.87	2,087	4
2024-04-01	Summy, Amy B.	Officer	EVP, Chief Marketing Officer	Direct	Sale	3,500	217.29	$760,515.00	3,975	4
2024-04-01	Schroeder, Mark S	Officer	EVP, Pres Diagnostics & COO	Direct	Sale	6,477	217.29	$1,407,387.33	5,036	4
2024-03-28	Van, Der Vaart Sandra D	Officer	EVP, Chief Legal Officer	Direct	Sale	3,553	216.74	$770,077.22	7,637	4
2024-03-07	Schroeder, Mark S	Officer	EVP, Pres Diagnostics & COO	Direct	Sale	5,048	218.45	$1,102,735.60	5,036	4
2024-03-07	Summy, Amy B.	Officer	EVP, Chief Marketing Officer	Direct	Sale	227	218.45	$49,588.15	3,859	4
2024-02-21	Eisenberg, Glenn A	Officer	Chief Financial Officer, EVP	Direct	Sale	34,504	216.64	$7,474,946.56	23,595	4
2024-02-21	Divincenzo, Jonathan P.	Officer	EVP, Pres, Central Labs & Intl	Direct	Sale	500	215.49	$107,745.00	3,401	4
2024-02-13	Van, Der Vaart Sandra D	Officer	EVP, Chief Legal Officer	Direct	Sale	237	226.45	$53,668.65	7,637	4
2024-02-08	Van, Der Vaart Sandra D	Officer	EVP, Chief Legal Officer	Direct	Sale	259	222.06	$57,513.54	7,637	4
2024-02-05	Van, Der Vaart Sandra D	Officer	EVP, Chief Legal Officer	Direct	Sale	193	220.57	$42,570.01	7,637	4
2023-11-16	Wilkinson, Peter J	Officer	SVP, Chief Accounting Officer	Direct	Sale	1,384	210.71	$291,622.64	2,087	4
2023-08-08	Anderson, Kerrii B	Director	-	Direct	Sale	5,000	211.57	$1,057,850.00	15,275	4
2023-06-29	Van, Der Vaart Sandra D	Officer	EVP, Chief Legal Officer	Direct	Sale	212	240.00	$50,880.00	7,605	4
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

88.31%

Inst. Shares: 72,681,123

Shares Outstanding: 82,300,000

2025-12-31

91.77%

Inst. Shares: 76,354,987

Shares Outstanding: 83,200,000

2025-09-30

88.93%

Inst. Shares: 73,899,467

Shares Outstanding: 83,100,000

2025-06-30

90.50%

Inst. Shares: 75,479,123

Shares Outstanding: 83,400,000

2025-03-31

87.20%

Inst. Shares: 72,899,157

Shares Outstanding: 83,600,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	72,681,123	82,300,000	88.31%
2025-12-31	76,354,987	83,200,000	91.77%
2025-09-30	73,899,467	83,100,000	88.93%
2025-06-30	75,479,123	83,400,000	90.50%
2025-03-31	72,899,157	83,600,000	87.20%
2024-12-31	74,294,345	83,900,000	88.55%
2024-09-30	70,714,468	84,000,000	84.18%
2024-06-30	72,534,554	84,100,000	86.25%
2024-03-31	70,765,369	84,100,000	84.14%
2023-12-31	73,734,873	87,100,000	84.66%
2023-09-30	73,460,053	86,600,000	84.83%
2023-06-30	71,481,263	88,700,000	80.59%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

LABCORP HOLDINGS INC. (LH) — SEC Financial Statements & Analysis

LABCORP HOLDINGS INC. (LH) is a services-medical laboratories company. LABCORP HOLDINGS INC. trades on LH: NYSE as: LH. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), LABCORP HOLDINGS INC. reported a 7.34% year-over-year revenue growth, a Gross Profit Margin of 28.83% (TTM), a Debt-to-Equity ratio of 1.18x, a Price-to-Sales (P/S) ratio of 1.55x (TTM), a Price-to-Book (P/B) ratio of 2.51 (TTM), at a market cap of $21.90B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 7.34%
Gross Profit Margin TTM: 28.83%
Debt To Equity: 1.18x
P/S TTM: 1.55x
P/B TTM: 2.51
Market Cap: $21.90B

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is LABCORP HOLDINGS INC. in?

LABCORP HOLDINGS INC. (LH) operates in the Services-Medical Laboratories industry.

What is LH's market cap?

LABCORP HOLDINGS INC. (LH) has a market capitalization of $21.90B as of 2026-03-31.

What is LH's P/E ratio?

LABCORP HOLDINGS INC. (LH)'s trailing twelve month P/E ratio is 23.26x as of 2026-03-31.

What exchange does LH trade on?

LABCORP HOLDINGS INC. (LH) trades on the LH: NYSE.

LABCORP HOLDINGS INC. (LH) — SEC Financial Statements & Analysis

Frequently Asked Questions

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.